✦ LIBER ✦

Randomized, Phase II, Placebo-Controlled, Double-Blind Study With and Without Enzastaurin in Combination With Paclitaxel and Carboplatin As First-Line Treatment Followed by Maintenance Treatment in Advanced Ovarian Cancer

✍ Scribed by Vergote, Ignace B. (author);Amant, Frederic (author);Chekerov, Radoslav (author);Sehouli, Jalid (author);Harter, Philipp (author);Bauknecht, Thomas (author);Mansouri, Kambiz (author);Casado, Antonio (author);Emerich, Janusz (author);Myrand, Scott P. (author);Nguyen, Tuan S. (author);Shi, Peipei (author)

Book ID: 121411741
Publisher: American Society of Clinical Oncology
Year: 2013
Tongue: English
Weight: 196 KB
Volume: 31
Category: Article
ISSN: 0732-183X
DOI: 10.1200/JCO.2012.44.9116

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized, Phase II, Placebo-Controlled

Randomized, Phase II, Placebo-Controlled, Double-Blind Study With and Without Enzastaurin in Combination With Paclitaxel and Carboplatin As First-Line Treatment Followed by Maintenance Treatment in Advanced Ovarian Cancer

✍ Vergote, Ignace B. (author);Amant, Frederic (author);Chekerov, Radoslav (author) 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 196 KB

Neuroprotection with amifostine in the f

Neuroprotection with amifostine in the first-line treatment of advanced ovarian cancer with carboplatin/paclitaxel-based chemotherapy—a double-blind, placebo-controlled, randomized phase II study from the Arbeitsgemeinschaft Gynäkologische Onkologoie (AGO) Ovarian Cancer Study Group

✍ F. Hilpert; A. Stähle; O. Tomé; A. Burges; D. Rossner; K. Späthe; V. Heilmann; B 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 185 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled, Phase II study with and without enzastaurin in combination with docetaxel-based chemotherapy in patients with castration-resistant metastatic prostate cancer

✍ Dreicer, Robert; Garcia, Jorge; Rini, Brian; Vogelzang, Nicholas; Srinivas, Sand 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 196 KB

Randomized phase II trial of carboplatin

Randomized phase II trial of carboplatin and paclitaxel with or without lonafarnib in first-line treatment of epithelial ovarian cancer stage IIB–IV

✍ Werner Meier; Andreas du Bois; Jörn Rau; Martina Gropp-Meier; Klaus Baumann; Jen 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 336 KB

Interferon-gamma in combination with car

Interferon-gamma in combination with carboplatin and paclitaxel as a safe and effective first-line treatment option for advanced ovarian cancer: results of a phase I/II study

✍ C. MARTH; G.H. WINDBICHLER; H. HAUSMANINGER; E. PETRU; K. ESTERMANN; A. PELZER; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

9007 Randomized, double-blind phase II/I

9007 Randomized, double-blind phase II/III study of first-line paclitaxel (P) plus carboplatin (C) in combination with vorinostat or placebo in patients with advanced non-small-cell lung cancer (NSCLC)

✍ Belani, C.; Ramalingam, S.; Kalemkerian, G.; Mok, T.; Rosell, R.; Ahn, M.J.; Sun 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 46 KB